Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J.L. Alcantara

Pdb70 - Economic Evaluation of the Use of Recombinant Human Epidermal Growth Factor (Heberprot-P®) as an Adjuvant of Conventional Therapy for the Treatment of Diabetic Foot Ulcer

Value in Health

English

Puk18 - Economic Evaluation of the Use of Sevelamer (Rifosar®) for the Treatment of Hyperphosphatemia in Patients With Chronic Renal Disease, From the Perspective of the Instituto Mexicano Del Seguro Social (Imss)

English

Related publications

Topical Recombinant Human Epidermal Growth Factor for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Controlled Clinical Trials

Annals of Vascular Surgery

Medicine

Surgery

Cardiovascular Medicine

Cardiology

2020

English

Analysis of the Clinical Application of Epidermal Growth Factor ("Heberprot-P") and Bioplastic Material ("Collost") in Treatment of Skin and Soft Tissues Defects in Patients With Diabetic Foot Syndrome

English

The Use of Recombinant Epidermal Growth Factor in Primary Health Assistance

Hospice and Palliative Medicine International Journal

2018

English

Epidermal Growth Factor Versus Conventional Wound Dressings in Treatment of Diabetic Ulcers- A Comparative Study

IOSR Journal of Dental and Medical Sciences

2017

English

Physical Therapy as an Adjuvant Treatment for the Prevention and Treatment of Cancer

Klinicka Onkologie

Oncology

2020

English

Angioplasty as an Adjuvant Therapy for the Treatment of Acute Ischemic Stroke

Canadian Journal of Neurological Sciences

Medicine

Neurology

2011

English

Case Report on the Use of a Honey on Diabetic Foot Ulcer Patients

International Journal of Indonesian National Nurses Association (IJINNA)

2018

English

Maggot Debridement Therapy for Diabetic Foot Ulcer: A Case Report

Journal of Critical Care Nursing

2017

English

Negative Pressure Therapy in the Surgical Treatment of Diabetic Foot

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J.L. Alcantara

Pdb70 - Economic Evaluation of the Use of Recombinant Human Epidermal Growth Factor (Heberprot-P®) as an Adjuvant of Conventional Therapy for the Treatment of Diabetic Foot Ulcer

Puk18 - Economic Evaluation of the Use of Sevelamer (Rifosar®) for the Treatment of Hyperphosphatemia in Patients With Chronic Renal Disease, From the Perspective of the Instituto Mexicano Del Seguro Social (Imss)

Related publications

Topical Recombinant Human Epidermal Growth Factor for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Controlled Clinical Trials

Analysis of the Clinical Application of Epidermal Growth Factor ("Heberprot-P") and Bioplastic Material ("Collost") in Treatment of Skin and Soft Tissues Defects in Patients With Diabetic Foot Syndrome

The Use of Recombinant Epidermal Growth Factor in Primary Health Assistance

Epidermal Growth Factor Versus Conventional Wound Dressings in Treatment of Diabetic Ulcers- A Comparative Study

Physical Therapy as an Adjuvant Treatment for the Prevention and Treatment of Cancer

Angioplasty as an Adjuvant Therapy for the Treatment of Acute Ischemic Stroke

Case Report on the Use of a Honey on Diabetic Foot Ulcer Patients

Maggot Debridement Therapy for Diabetic Foot Ulcer: A Case Report

Negative Pressure Therapy in the Surgical Treatment of Diabetic Foot